XBiotech Inc (XBIT)
8.21
+0.14
(+1.73%)
USD |
NASDAQ |
Apr 25, 16:00
8.15
-0.06
(-0.73%)
After-Hours: 20:00
XBiotech Cash from Financing (TTM)
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2021 | -67.01M |
| September 30, 2021 | -67.19M |
| June 30, 2021 | 7.078M |
| March 31, 2021 | 3.38M |
| December 31, 2020 | -409.72M |
| September 30, 2020 | -406.40M |
| June 30, 2020 | -408.34M |
| March 31, 2020 | -370.73M |
| December 31, 2019 | 42.10M |
| September 30, 2019 | 38.92M |
| June 30, 2019 | 38.64M |
| March 31, 2019 | 0.741M |
| December 31, 2018 | 0.201M |
| September 30, 2018 | 0.205M |
| June 30, 2018 | 0.25M |
| Date | Value |
|---|---|
| March 31, 2018 | 0.811M |
| December 31, 2017 | 33.32M |
| September 30, 2017 | 35.40M |
| June 30, 2017 | 35.51M |
| March 31, 2017 | 35.66M |
| December 31, 2016 | 2.944M |
| September 30, 2016 | 0.868M |
| June 30, 2016 | 0.739M |
| March 31, 2016 | 75.36M |
| December 31, 2015 | 77.47M |
| September 30, 2015 | 123.32M |
| June 30, 2015 | 129.03M |
| March 31, 2015 | 53.70M |
| December 31, 2014 | 63.20M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-409.72M
Minimum
Dec 2020
42.10M
Maximum
Dec 2019
-145.39M
Average
-67.01M
Median
Dec 2021
Cash from Financing (TTM) Benchmarks
| NovaBay Pharmaceuticals Inc | 1.91M |
| Palatin Technologies Inc | 5.553M |
| iBio Inc | 10.68M |
| Theriva Biologics Inc | 0.625M |
| Oragenics Inc | 0.2839M |